Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability study. 1991

A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
Division of Oncology, University Kantonsspital, Basel, Switzerland.

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias

Related Publications

A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
August 1988, Behring Institute Mitteilungen,
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
January 1992, European journal of cancer (Oxford, England : 1990),
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
August 1988, Behring Institute Mitteilungen,
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
May 1993, Bulletin du cancer,
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
January 1989, British journal of cancer,
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
September 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
April 1989, Seminars in hematology,
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
August 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
April 1988, Lancet (London, England),
A Dieterle, and A Gratwohl, and R Ritz, and J P Obrecht, and R Obrist
March 1988, The New England journal of medicine,
Copied contents to your clipboard!